Cameco Corporation, a NYSE listed company (symbol CCJ), is a uranium producer and one of the world’s largest. The company’s stock price has been trading around $28.79 with 0.1391% change from the previous day and 0.04% change during the day according to last updates. Market cap is approximately $12.46 bln, 52-week high was at $32.49 and 52-week low at $20.02 per share accordingly.
Analyzing Cameco Corporation’s revenue for the past five quarters reveals some interesting facts about its financial situation. Revenue in Q2 2023 was estimated to be around $340 mln while actual revenue was 0 due to Covid19 pandemic impact on the sector as well as price volatility in uranium markets, but it possibly might get stronger in near future due to recovery of these markets and production scale up plans announced by Cameco recently. During Q3 2022 revenue amounted to $388 mln, whereas reported back in Q4 2021 it was as much as $465 mln with EPS of 0.05 respectively. Q1 2022 showed slightly lower numbers both for revenue ($398 mln) and EPS (<0.02).
It is obvious that Cameco Corporation had difficulties due to Covid19 outbreak, but the results still appear stable over time which gives investors hope for its further success in upcoming periods when global market will recover from coronavirus effects more quickly than expected now which obviously can potentially increase demand for Cameco’s commodities significantly resulting in higher revenues and profit margins accordingly considering company’s strategy of cost optimization activities taken before pandemic started globally which provided competitive advantage over competitors during crisis times being able to keep production level relatively close to pre-covid 19 periods
